These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8931739)

  • 1. Effects of methyl substitutions on benz[a]anthracene derivatives-induced immunosuppression.
    Saas P; Bohuon C; Pallardy M
    J Toxicol Environ Health; 1996 Nov; 49(4):371-87. PubMed ID: 8931739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
    Wood AW; Levin W; Chang RL; Conney AH; Slaga TJ; O'Malley RF; Newman MS; Buhler DR; Jerina DM
    J Natl Cancer Inst; 1982 Sep; 69(3):725-8. PubMed ID: 6810009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of micronuclei and sister chromatid exchanges by polycyclic and N-heterocyclic aromatic hydrocarbons in cultured human lymphocytes.
    Warshawsky D; Livingston GK; Fonouni-Fard M; LaDow K
    Environ Mol Mutagen; 1995; 26(2):109-18. PubMed ID: 7556107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative metabolism of 7-methylbenz[a]anthracene, 12-methylbenz[a]anthracene and 7,12-dimethylbenz[a]anthracene by rat liver cytosol.
    Flesher JW; Myers SR
    Cancer Lett; 1985 Feb; 26(1):83-8. PubMed ID: 3918789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice.
    DiGiovanni J; Diamond L; Singer JM; Daniel FB; Witiak DT; Slaga TJ
    Carcinogenesis; 1982; 3(6):651-5. PubMed ID: 6811143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase: effects of methyl substitution on velocity and stereochemical course of trans-dihydrodiol oxidation.
    Smithgall TE; Harvey RG; Penning TM
    Cancer Res; 1988 Mar; 48(5):1227-32. PubMed ID: 3124956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumorigenicity of 7,12-dimethylbenz[a]anthracene, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse.
    Wislocki PG; Juliana MM; MacDonald JS; Chou MW; Yang SK; Lu AY
    Carcinogenesis; 1981; 2(6):511-4. PubMed ID: 6791859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons.
    DiGiovanni J; Rymer J; Slaga TJ; Boutwell RK
    Carcinogenesis; 1982; 3(4):371-5. PubMed ID: 6284398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin tumor initiating activities of the 9- and 10-fluoro derivatives of 7- or 12-methylbenz[a]anthracene and the 9- and 10-trifluoromethyl derivatives of 7,12-dimethylbenz[a]anthracene in SENCAR mice.
    Sawyer TW; Fisher EP; DiGiovanni J
    Carcinogenesis; 1987 Oct; 8(10):1465-8. PubMed ID: 3115616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UVA light-induced DNA cleavage by isomeric methylbenz[a]anthracenes.
    Dong S; Fu PP; Shirsat RN; Hwang HM; Leszczynski J; Yu H
    Chem Res Toxicol; 2002 Mar; 15(3):400-7. PubMed ID: 11896688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shapes of carcinogenic benz[alpha]anthracenes: an x-ray crystal structure analysis of 12-methylbenz[alpha]anthracene.
    Jones DW; Sowden JM
    Cancer Biochem Biophys; 1976; 1(6):281-8. PubMed ID: 1016936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice.
    Wissing KM; Desalle F; Abramowicz D; Willems F; Leo O; Goldman M; Alegre ML
    Transplantation; 1999 Sep; 68(5):677-84. PubMed ID: 10507488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.
    Wang JX; Tang W; Shi LP; Wan J; Zhou R; Ni J; Fu YF; Yang YF; Li Y; Zuo JP
    Br J Pharmacol; 2007 Mar; 150(5):652-61. PubMed ID: 17262016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor initiating activity of 9- and 10-fluoro-7,12-dimethylbenz[a]-anthracene (DMBA) and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on tumor initiation by monofluoro derivatives of DMBA in SENCAR mice.
    DiGiovanni J; Decina PC; Diamond L
    Carcinogenesis; 1983 Aug; 4(8):1045-9. PubMed ID: 6409443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 7,12-dimethylbenz(a)anthracene and 7-hydroxymethyl-12-methylbenz(a)anthracene by rat liver and microsomes.
    Chou MW; Yang SK; Sydor W; Yang CS
    Cancer Res; 1981 Apr; 41(4):1559-64. PubMed ID: 6783297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2.
    Elliott L; Brooks W; Roszman T
    Cell Mol Neurobiol; 1993 Dec; 13(6):579-92. PubMed ID: 7910781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic effects of methylated benz[a]anthracenes in liver cells.
    Marvanová S; Vondrácek J; Penccíková K; Trilecová L; Krcmárr P; Topinka J; Nováková Z; Milcová A; Machala M
    Chem Res Toxicol; 2008 Feb; 21(2):503-12. PubMed ID: 18205319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone.
    Ladics GS; Kawabata TT; White KL
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):31-44. PubMed ID: 1908145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro.
    Thurmond LM; House RV; Lauer LD; Dean JH
    Toxicol Appl Pharmacol; 1988 May; 93(3):369-77. PubMed ID: 2835829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
    Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
    Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.